The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Johannes Hans W. Louwerenburg

Showing 1-8 of 8 articles
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
Zocca P, van der Heijden LC, Kok M, Löwik M, Hartmann M, Stoel M, Louwerenburg H, de Man F, Linssen GCM, Knottnerus I, Doggen CJM, van Houwelingen K, von Birgelen C
November 20, 2017 | 10.4244/EIJ-D-17-00634
Coronary interventions
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial
Tandjung K, Lam MK, Sen H, de Man F, Louwerenburg H, Stoel M, van Houwelingen K, Linssen GCM, van der Palen J, Doggen CJM, von Birgelen C
July 20, 2016 | 10.4244/EIJY15M08_01
Coronary interventions
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study
Kok M, von Birgelen C, Lam MK, Löwik M, van Houwelingen K, Stoel M, Louwerenburg H, de Man F, Hartmann M, Doggen CJM, van Til J, IJzerman M
April 20, 2016 | 10.4244/EIJY15M10_06
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial
Lam MK, Tandjung K, Sen H, Basalus M, van Houwelingen K, Stoel M, Louwerenburg H, Linssen GCM, Said S, Nienhuis M, de Man F, van der Palen J, von Birgelen C
June 19, 2015 | 10.4244/EIJV11I2A32
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial
Löwik M, Lam MK, Sen H, Tandjung K, van Houwelingen K, de Man F, Stoel M, Louwerenburg H, Linssen GCM, Doggen CJM, von Birgelen C
March 20, 2015 | 10.4244/EIJY14M08_11
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial
Sen H, Lam MK, Tandjung K, Basalus M, de Man F, Louwerenburg H, Stoel M, van Houwelingen K, Löwik M, Linssen GCM, Said S, Nienhuis M, Verhorst P, van der Palen J, von Birgelen C
October 20, 2014 | 10.4244/EIJV10I6A117
Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents
Sen H, Tandjung K, Basalus M, L M, van Houwelingen K, Stoel M, Louwerenburg H, de Man F, Linssen GCM, Nijhuis R, Nienhuis M, Verhorst P, van der Palen J, von Birgelen C
October 26, 2012 | 10.4244/EIJV8I6A104
Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry
de Man F, Tandjung K, Hartmann M, van Houwelingen K, Stoel M, Louwerenburg H, Basalus M, Sen H, Löwik M, von Birgelen C
July 27, 2012 | 10.4244/EIJV8I3A52

Latest news

Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke